
### [MONDO:0021355](http://purl.obolibrary.org/obo/MONDO_0021355)
**Label:** neoplasm of esophagus

**Subclasses:** [MONDO:0004837](http://purl.obolibrary.org/obo/MONDO_0004837) (neurofibroma of the esophagus), [MONDO:0003649](http://purl.obolibrary.org/obo/MONDO_0003649) (esophageal neuroendocrine tumor), [MONDO:0018480](http://purl.obolibrary.org/obo/MONDO_0018480) (carcinoma of esophagus, salivary gland type), [MONDO:0018481](http://purl.obolibrary.org/obo/MONDO_0018481) (undifferentiated carcinoma of esophagus), [MONDO:0004832](http://purl.obolibrary.org/obo/MONDO_0004832) (esophagus leiomyoma), [MONDO:0001204](http://purl.obolibrary.org/obo/MONDO_0001204) (esophagus sarcoma), [MONDO:0021459](http://purl.obolibrary.org/obo/MONDO_0021459) (benign neoplasm of esophagus), [MONDO:0001188](http://purl.obolibrary.org/obo/MONDO_0001188) (esophagus lymphoma), [MONDO:0005028](http://purl.obolibrary.org/obo/MONDO_0005028) (esophageal adenocarcinoma), [MONDO:0004116](http://purl.obolibrary.org/obo/MONDO_0004116) (esophagus small cell carcinoma), [MONDO:0003365](http://purl.obolibrary.org/obo/MONDO_0003365) (esophagus leiomyosarcoma), [MONDO:0003586](http://purl.obolibrary.org/obo/MONDO_0003586) (esophagus liposarcoma), [MONDO:0003186](http://purl.obolibrary.org/obo/MONDO_0003186) (esophageal adenoid cystic carcinoma), [MONDO:0005580](http://purl.obolibrary.org/obo/MONDO_0005580) (esophageal squamous cell carcinoma), [MONDO:0004093](http://purl.obolibrary.org/obo/MONDO_0004093) (esophageal basaloid carcinoma), [MONDO:0004708](http://purl.obolibrary.org/obo/MONDO_0004708) (esophagus carcinoma in situ), [MONDO:0004827](http://purl.obolibrary.org/obo/MONDO_0004827) (esophagus squamous cell papilloma), [MONDO:0021324](http://purl.obolibrary.org/obo/MONDO_0021324) (malignant neoplasm of abdominal esophagus), [MONDO:0021326](http://purl.obolibrary.org/obo/MONDO_0021326) (malignant neoplasm of cervical esophagus), [MONDO:0004405](http://purl.obolibrary.org/obo/MONDO_0004405) (Barrett adenocarcinoma), [MONDO:0019086](http://purl.obolibrary.org/obo/MONDO_0019086) (carcinoma of esophagus), [MONDO:0021325](http://purl.obolibrary.org/obo/MONDO_0021325) (malignant neoplasm of thoracic esophagus), [MONDO:0000963](http://purl.obolibrary.org/obo/MONDO_0000963) (esophageal lipoma), [MONDO:0002762](http://purl.obolibrary.org/obo/MONDO_0002762) (esophagus verrucous carcinoma), [MONDO:0003550](http://purl.obolibrary.org/obo/MONDO_0003550) (esophageal adenosquamous carcinoma), [MONDO:0007576](http://purl.obolibrary.org/obo/MONDO_0007576) (esophageal cancer), [MONDO:0003251](http://purl.obolibrary.org/obo/MONDO_0003251) (esophageal granular cell tumor), [MONDO:0003093](http://purl.obolibrary.org/obo/MONDO_0003093) (mucoepidermoid esophageal carcinoma), [MONDO:0001192](http://purl.obolibrary.org/obo/MONDO_0001192) (esophagus melanoma), 

**Mapped go classes:** [GO:0014069](http://purl.obolibrary.org/obo/GO_0014069) (postsynaptic density), [GO:0016605](http://purl.obolibrary.org/obo/GO_0016605) (PML body), [GO:0007179](http://purl.obolibrary.org/obo/GO_0007179) (transforming growth factor beta receptor signaling pathway), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:0021952](http://purl.obolibrary.org/obo/GO_0021952) (central nervous system projection neuron axonogenesis), [GO:0007178](http://purl.obolibrary.org/obo/GO_0007178) (transmembrane receptor protein serine/threonine kinase signaling pathway), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0044314](http://purl.obolibrary.org/obo/GO_0044314) (protein K27-linked ubiquitination), [GO:0060765](http://purl.obolibrary.org/obo/GO_0060765) (regulation of androgen receptor signaling pathway), [GO:0050431](http://purl.obolibrary.org/obo/GO_0050431) (transforming growth factor beta binding), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0045211](http://purl.obolibrary.org/obo/GO_0045211) (postsynaptic membrane), [GO:0043198](http://purl.obolibrary.org/obo/GO_0043198) (dendritic shaft), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0043197](http://purl.obolibrary.org/obo/GO_0043197) (dendritic spine), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0048167](http://purl.obolibrary.org/obo/GO_0048167) (regulation of synaptic plasticity), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0005042](http://purl.obolibrary.org/obo/GO_0005042) (netrin receptor activity), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0004872](http://purl.obolibrary.org/obo/GO_0004872) (receptor activity), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0040008](http://purl.obolibrary.org/obo/GO_0040008) (regulation of growth), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0048846](http://purl.obolibrary.org/obo/GO_0048846) (axon extension involved in axon guidance), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0004702](http://purl.obolibrary.org/obo/GO_0004702) (signal transducer, downstream of receptor, with serine/threonine kinase activity), [GO:0043161](http://purl.obolibrary.org/obo/GO_0043161) (proteasome-mediated ubiquitin-dependent protein catabolic process), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0050681](http://purl.obolibrary.org/obo/GO_0050681) (androgen receptor binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0044297](http://purl.obolibrary.org/obo/GO_0044297) (cell body), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0016242](http://purl.obolibrary.org/obo/GO_0016242) (negative regulation of macroautophagy), [GO:0033564](http://purl.obolibrary.org/obo/GO_0033564) (anterior/posterior axon guidance), [GO:0031103](http://purl.obolibrary.org/obo/GO_0031103) (axon regeneration), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:0061630](http://purl.obolibrary.org/obo/GO_0061630) (ubiquitin protein ligase activity), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0044772](http://purl.obolibrary.org/obo/GO_0044772) (mitotic cell cycle phase transition), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0048814](http://purl.obolibrary.org/obo/GO_0048814) (regulation of dendrite morphogenesis), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0048665](http://purl.obolibrary.org/obo/GO_0048665) (neuron fate specification), [GO:0071678](http://purl.obolibrary.org/obo/GO_0071678) (olfactory bulb axon guidance), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0016358](http://purl.obolibrary.org/obo/GO_0016358) (dendrite development), [GO:0038006](http://purl.obolibrary.org/obo/GO_0038006) (netrin receptor activity involved in chemoattraction), [GO:0070936](http://purl.obolibrary.org/obo/GO_0070936) (protein K48-linked ubiquitination), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0060218](http://purl.obolibrary.org/obo/GO_0060218) (hematopoietic stem cell differentiation), [GO:0005026](http://purl.obolibrary.org/obo/GO_0005026) (transforming growth factor beta receptor activity, type II), [GO:0021960](http://purl.obolibrary.org/obo/GO_0021960) (anterior commissure morphogenesis), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0006511](http://purl.obolibrary.org/obo/GO_0006511) (ubiquitin-dependent protein catabolic process), [GO:0008017](http://purl.obolibrary.org/obo/GO_0008017) (microtubule binding), [GO:0004842](http://purl.obolibrary.org/obo/GO_0004842) (ubiquitin-protein transferase activity), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0030516](http://purl.obolibrary.org/obo/GO_0030516) (regulation of axon extension), [GO:0031965](http://purl.obolibrary.org/obo/GO_0031965) (nuclear membrane), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0030517](http://purl.obolibrary.org/obo/GO_0030517) (negative regulation of axon extension), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0085020](http://purl.obolibrary.org/obo/GO_0085020) (protein K6-linked ubiquitination), 

**Class expressions from DL-Learner:**

- [GO:0045211](http://purl.obolibrary.org/obo/GO_0045211) (postsynaptic membrane) 52.94%
- [GO:0043198](http://purl.obolibrary.org/obo/GO_0043198) (dendritic shaft) 52.94%
- [GO:0038006](http://purl.obolibrary.org/obo/GO_0038006) (netrin receptor activity involved in chemoattraction) 52.94%
- [GO:0016605](http://purl.obolibrary.org/obo/GO_0016605) (PML body) 52.94%
- [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane) 52.94%
- [GO:0005042](http://purl.obolibrary.org/obo/GO_0005042) (netrin receptor activity) 52.94%
- [GO:0005026](http://purl.obolibrary.org/obo/GO_0005026) (transforming growth factor beta receptor activity, type II) 52.94%
- Thing 52.64%
- [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity) 38.30%
- [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:1990271](http://purl.obolibrary.org/obo/GO_1990271) (obsolete anti-Mullerian hormone)) 38.30%
- [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:1990242](http://purl.obolibrary.org/obo/GO_1990242) (obsolete innate immune response complex)) 38.30%
- [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:1990241](http://purl.obolibrary.org/obo/GO_1990241) (obsolete nucleotide binding complex)) 38.30%
- [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:1990187](http://purl.obolibrary.org/obo/GO_1990187) (obsolete protein localization to mRNA)) 38.30%
- [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:1990149](http://purl.obolibrary.org/obo/GO_1990149) (obsolete COPI vesicle coating)) 38.30%
- [GO:0005024](http://purl.obolibrary.org/obo/GO_0005024) (transforming growth factor beta-activated receptor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:1990132](http://purl.obolibrary.org/obo/GO_1990132) (obsolete release of misfolded protein from chaperone)) 38.30%


